Main Article Content
Background and Objective: Extended Spectrum β-lactamase (ESBL) producing Urinary Tract Infection (UTI) is an important public health issue due to lack of therapeutic antibiotic options and the danger it portends to the pregnant woman. This study was carried out to determine the prevalence and response to antimicrobials of ESBL-producing uropathogenic E. coli and K. pneumoniae, among pregnant women on ante natal care.
Study Design/Materials and Methods: Two hundred and fifteen pregnant women across three different hospitals in Nnewi North L.G.A of Anambra State were screened for these uropathogens. Modified Double Disc Synergy test (MDDST) was carried out on the isolates to phenotypically determine the presence of ESBL. Plasmid profiling as well as plasmid curing studies were undertaken. Molecular characterization of the phenotypically confirmed ESBL positive isolate via Polymearse Chain Reaction (PCR) was carried out using three ESBL primers (bla-TEM, bla-SHV, bla-CTX-M).
Results: 192 isolates were obtained of which 75(39.1%) were E. coli and 117(60.9%) were K. pneumoniae. A total of 130 (67.7%) of the pregnant women had ESBL-mediated UTI, the highest rate reported in recent times in Nigeria. Molecular characterization of the ESBL types revealed a predominance of bla-TEM (91.9%), followed by bla-SHV (73.3%) and bla-CTX-M (56.8%).
Conclusion: The Majority of the isolates harbored multiple ESBL genes. Curing studies were largely ineffectual as most of the isolates retained their resistance determinants regardless of the concentration of the curing agent (acridine orange).
Odimegwu DC, Afunwa A, Iroha RI, Esimone CO. Antimicrobial resistance status and prevalence rates of extended spectrum Beta-lactamase producers Isolated from a mixed human population. Bosnian Journal of Basic Medical Sciences. 2011;11(2):91-96.
Mohanty S, Gaind R, Ranjan R, Deb M. Use of the Cefepime-clavulanate ESBL E-test for Detection of Extended-Spectrum Beta-lactamases in AmpC Co-producing Bacteria. Journal of Infection in Developing Countries. 2009;21(4):24-29.
Doddaiah V, Anjaneya D. Prevalence of ESBL, AmpC and Carbapenemase among Gram Negative Bacilli Isolated from Clinical Specimens. American Journal of Life Science. 2014;2:76–81.
Kaur J, Mahajan G, Chand K, Chopra S. Enhancing phenotypic detection of ESBL in ampc co-producers by using cefepime and tazobactam. Journal of Clinical and Diagnostic Research. 2016;10(1):229-233.
Khanfar HS, Bindayna KM, Senok AC, Botta GA. Extended-spectrum Beta-lactamases (ESBL) In E.Coli And K. Pneumoniae: Trends in the hospital and community setting. Journal of Infection in Developing Countries. 2009;3:295-299.
Kotra LP, Samama J, Mobashery S. Β-lactamases and resistance to Β-lactam antibiotics. In: Lewis K, Salyers AA, Tabar HW, Wax RG. Edn. Bacterial resistance to antimicrobials. New York, Marcel Decker. 2002;123-60.
Maina D, Makau P, Nyerere A, Revathi G. Antimicrobial resistance patterns in extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae isolates in a private tertiary hospital, Kenya. Microbiology Discovery. 2013;1(5):1-4.
Fang H, Ferda A, Göran H, Dornbusch K. Molecular epidemiology of extended-spectrum β-lactamases among Escherichia Coli isolates collected in a swedish hospital and its associated health care facilities from 2001 to 2006. Journal of Clinical Microbiology. 2008;46(2):707-712.
Oluduro AO, Aregbesola OA, Fashina CD. Extended spectrum beta- lactamase- producing uropathogenic Escherichia coli in pregnant women diagnosed with urinary tract infections in South-Western Nigeria. Journal of Molecular Biology Research. 2014;4(1):34-41.
Iroha IR, Amadi ES, Nwazo AC, Ejike-Ugwu PC. Detection of plasmid borne ESBLs from blood and urine isolates of gram negative bacteria from University Teaching Hospital In Nigeria. Current Research in Bacteriology. 2010;3:77-83.
Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G. Changing the face of ESBLs in Europe. Journal of Antimicrobials and Chemotherapy. 2007;59(2):165–174.
Delzell JE, Lefevre MI. Urinary tract infection during pregnancy. American Family Physician. 2000;61(3):713-721.
Mazor-day E, Levy A, Schlaeffer F, Sheiner E. Maternal urinary tract infection: Is it independently associated with adverse pregnancy outcome? Journal of Maternal-Fetal and Neonatal Medicine. 2009;22(2): 124-128.
Kaur J, Chopra S, Mahajan G. Modified double disc synergy test to detect ESBL production in urinary isolates of Escherichia coli and Klebsiella pneumonia. Journal of Clinical and Diagnostic Research. 2013;7(2):229-233.
Clinical and laboratory standards institute, CLSI. Performance standards for antimicrobial disk susceptibility tests, (Approved standard—Eleventh Edition), Clinical and Laboratory Standards Institute, Wayne, Pa, USA;2017.
Ezeonu IM, Okafor JI, Ogbonna JC. Laboratory exercises in microbiology, ephrata printing and publishing company. 2011;39–194.
Kraft R, Tardiff J, Krauter KS, Leinwand L A. Using Mini-prep plasmid DNA for sequencing double stranded template with sequences. Biotechnology. 1988;6:544.
Otajevwo F, Okungbowa A. Study on resistance loss of multidrug resistant (MDR) Pseudomonas Aeruginosa strains after treatment with dilutions of acridine orange. International Journal of Medicine and Medical Sciences. 2014;6(1):24-33.
Uddin MN, Khan T. Prevalence of urinary tract infection among pregnant women at ibrahim iqbal memorial hospital, Chandanaish, Bangladesh. American Journal of Clinical Medicine Research. 2016;4(3):47-51.
Aibinu IE, Ohagbulam VC, Adenipekun E A, Ogunsola FT, Odugbemi TO, Mee BJ. Extended–spectrum Beta-lactamase enzymes in clinical isolates of enterobacter species from lagos, Nigeria. Journal of Clinical Microbiology. 2003;41(5):2197-2200.
Mahesh E, Ramesh D, Indumathi VA, Punith K, Raj K, Anupama H. Complicated Urinary tract infection in a tertiary care center In South India. Al Ameen Journal of Medical Sciences. 2010;3:120–122.
Padmavathy. Fluoroquinolone resistance among CTX-M producing uropathogenic Escherichia coli from HIV and non-HIV patients in South India BMC infectious Diseases. 2014;14(Suppl3):63.
Ranjan KP, Ranjan N. Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli. Urology annals. 2014;6:112-113.
Tokumori FC, Salgado IC, Malaga G. Worrisome high frequency of extended-spectrum Beta- Lactamase-producing Escherichia coli In Community-acquired urinary tract infections: A case–control study. International Journal of Infectious Diseases. 2017;55:16-19.
Aminzadeh Z, Sadat KM, Sha'bani M. Bacteriuria by Extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Isolates in a governmental hospital in South of Tehran, Iran. Iranian Journal of Kidney Diseases. 2008;2(4):197-200.
Shakya P, Shrestha D, Maharjan E, Sharma VK, Paudyal R. ESBL production among E. coli and Klebsiella spp. Causing urinary tract infection: A Hospital Based Study, Open Microbiology Journal. 2017; 11:23–30.
Yusha’u MM, Olonitola SO, Aliyu BS. Prevalence of extended-spectrum β-lactamases (ESBLS) producing enterobacteriaceae in Kano, Nigeria. International Journal of Biomedical & Health Sciences. 2009;5(2):79-86.
Ezeigbo OR, Nnadozie N, Asuoha-Chuks VU, Ojiako IN, Ugochukwu MG. Incidence of Urinary Tract Infection (UTI) among pregnant women attending antenatal clinics at some selected hospitals in Aba, Southeastern Nigeria. International Journal of Current Microbiology and Applied Science. 2016;5(1):193-199.
Parajuli NP, Maharjan P, Joshi G, Khanal1, RK. Emerging perils of extended spectrum
Pokhrel RH, Thapa B, Kafle R, Shah PK, Tribuddharat C. Co-existence of Beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal, BMC Research Notes. 2014; 7:694.
Bali EB, Sultan N. Phenotypic and molecular characterization of SHV, TEM,CTX-M and Extended-spectrum